We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




CTI Acquires Mirada Solutions

By HospiMedica staff writers
Posted on 12 Sep 2003
In a move to enhance the company's positron emission tomography (PET) systems, CTI Molecular Imaging, Inc. (Knoxville, TN, USA) has acquired Mirada Solutions Limited (Oxford, UK). Terms were not disclosed.

Mirada, a spinoff from Oxford University, is a developer of fusion software applications for medical imaging workstations. CTI plans to incorporate Mirada's image analysis and fusion software into all its PET scanner workstations, to enhance the analytical and diagnostic capabilities of its PET systems. Mirada has developed several products designed to provide better detection, diagnosis, and disease management through the application of image analysis software to medical images.

"We believe that we have acquired the best-in-class capability that will further distinguish our PET scanners in the marketplace,” said Terry Douglas, chairman and CEO of CTI. "With this acquisition, we not only offer the fastest scan time through our proprietary LSO technology, but we also provide the greatest level of PET image functionality for the clinician.”





Related Links:
CTI
Mirada
Biopsy Software
Affirm® Contrast
Computed Tomography System
Aquilion ONE / INSIGHT Edition
Digital Radiography System (Ceiling Free)
Digix CF Series
MRI System
nanoScan MRI 3T/7T

Channels

Imaging IT

view channel
Image: Researchers develop a vision-language model trained on large-scale data to generate clinically relevant findings from chest computed tomography images through visual question answering (Ms. Maiko Nagao from Meijo University, Japan)

Interactive AI Tool Supports Explainable Lung Nodule Assessment

Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.